Suppression by azelastine hydrochloride of NF-κB activation involved in generation of cytokines and nitric oxide

Japanese Journal of Pharmacology

Volumn 73, Issue 2, 1997, Pages 145-153

  Yoneda, Kazunori ^a   Yamamoto, Tetsuya ^a   Ueta, Eisaku ^a   Osaki, Tokio ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Azelastine hydrochloride; Cytokine; NF B; Nitric oxide synthase

Indexed keywords

AZELASTINE; BETA ACTIN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DOSE RESPONSE; DRUG MECHANISM; FIBROBLAST; HUMAN; HUMAN CELL; LYMPHOCYTE TRANSFORMATION; MONOCYTE; MOUSE; NONHUMAN; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PERITONEUM MACROPHAGE; PROTEIN SYNTHESIS INHIBITION;

EID: 0030892875     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.73.145     Document Type: Article

References (41)

1. Chand N, Pillar J, Diamantis W and Sofia RD: Inhibition of allergic histamine release by azelastine and selected antiallergic drugs from rabbit leukocytes. Int Arch Allergy Appl Immunol 77, 451-455 (1985)
2. Spector SL, Perhach JL, Rohr AS, Rachelefsky GS, Katz RM and Siegel SC: Pharmacodynamic evaluation of azelastine in subjects with asthma. J Allergy Clin Immunol 80, 75-80 (1987)
3. Katayama S, Akimoto N, Shionoya H, Morimoto T and Katoh Y: Anti-allergic effect of azelastine hydrochloride on immediate type hypersensitivity reactions in vivo and in vitro. Arzneimittelforschung 31, 1196-1203 (1981)
4. Tanigawa T, Honda M and Miura K: Effect of azelastine hydrochloride on vascular permeability in hypersensitivity reaction skin site in guinea pig. Drug Res 31, 1212-1215 (1981)
5. Ueta E, Osaki T, Kawasaki N and Nomura Y: Suppression of respiratory burst of polymorphonuclear leukocytes by azelastine hydrochloride (Azeptin). Eur J Clin Pharmacol 47, 139-145 (1994)
6. Ueta E, Osaki T, Yoneda K and Yamamoto T: Contrasting influence of peplomycin and azelastine hydrochloride (Azeptin) on reactive oxygen generation in polymorphonuclear leukocytes, cytokine generation in lymphocytes, and collagen synthesis in fibroblasts. Cancer Chemother Pharmacol 35, 230-236 (1995)
7. Juretic A, Spagnoli GC, Hörig H, Shipman R, Kocher T, Samija M and Turic M: Tyrosine kinase-dependent and -independent events induced by interleukin-2 stimulation: interleukin-2-mediated NO production required for the induction of lymphokine-activated killer cell activity in rat splenocytes is tyrosine kinase independent. Immunology 85, 325-330 (1995)
8. Caterina RD, Libby P, Peng H-B, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS and Kiao JK: Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96, 60-68 (1995)
9. Kaplan SS, Lancaster JR Jr, Basford RE and Simmons RL: Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide. Infect Immun 64, 69-76 (1996)
10. Marcinkiewicz J, Grabowska A and Chain B: Nitric oxide upregulates the release of inflammatory mediators by mouse macrophages. Eur J Immunol 25, 947-951 (1995)
11. Schütze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K and Krönke M: TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71, 765-776 (1992)
12. Los M, Droge W, Stricker K, Baeuerle PA and Schulze-Osthoff K: Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur J Immunol 25, 159-165 (1995)
13. Hecker M, Preiß C, Schini-Kerth VB and Busse R: Anti-oxidants differentially affect nuclear factor κB-mediated nitric oxide synthase expression in vascular smooth muscle cells. FEBS Lett 380, 224-228 (1996)
14. Chartrain NA, Geller DA, Koty PP, Sitrin NF, Nussler AK, Hoffman EP, Billiar TR, Hutchinson NI and Mudgett JS: Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 269, 6765-6772 (1994)
15. Ueta E, Osaki T, Yoneda K and Yamamoto T: Upregulation of respiratory burst of polymorphonuclear leukocytes by a bleomycin derivative, peplomycin. Free Rad Res 22, 533-544 (1995)
16. Cenci E, Romani L, Mencacci A, Spaccapelo R, Schiaffella E, Puccetti P and Bistoni F: Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 23, 1034-1038 (1993)
17. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254 (1976)
18. Suzuki YJ, Mizuno M and Packer L: Signal transduction for nuclear factor-κB activation, proposed location of antioxidant-inhibitable step. J Immunol 153, 5008-5015 (1994)
19. Cattell V, Cook T and Moncada S: Glomeruli synthesize nitrite in experimental nephrotoxic nephritis. Kidney Int 38, 1056-1060 (1990)
20. Parks DA and Granger DN: Ischemia-induced vascular changes: role of xanthine oxidase and hydroxyl radicals. Am J Physiol 245, 285-289 (1983)
21. Repine JE: Scientific perspectives on adult respiratory distress syndrome. Lancet 339, 466-469 (1992)
22. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Pallandino MA Jr and Shepard HM: Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 230, 943-945 (1985)
23. Thomson BM, Mundy GR and Chambers TJ: Tumor necrosis factors α and β induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 138, 775-779 (1987)
24. Stashenko P, Fujiyoshi P, Obernesser MS, Prostak L, Haffajee AD and Socransky SS: Levels of interleukin 1 beta in tissue from sites of active periodontal disease. J Clin Periodontol 18, 548-554 (1991)
25. Nishimoto N, Yoshizaki K, Tagoh H, Monden M, Kishimoto S, Hirano T and Kishimoto T: Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation. Clin Immunol Immunopathol 50, 399-401 (1989)
26. Shimizu N, Ogura N, Yamaguchi M, Goseki T, Shibata Y, Abiko Y, Iwasawa T and Takiguchi H: Stimulation by interleukin-1 of interleukin-6 production by human periodontal ligament cells. Arch Oral Biol 37, 743-748 (1992)
27. Gasson JC: Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77, 1131-1145 (1991)
28. Dedhar S, Gaboury L, Galloway P and Eaves C: Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin. Proc Natl Acad Sci USA 85, 9253-9257 (1988)
29. Brumell JH, Burkhardt AL, Bolen JB and Grinstein S: Endogenous reactive oxygen intermediates activate tyrosine kinases in human neutrophils. J Biol Chem 19, 1455-1461 (1996)
30. Ferrante A: Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: Increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect Immun 57, 2115-2122 (1989)
31. lck in T cells. Oncogene 8, 3133-3139 (1993)
32. Los M, Droge W, Stricker K, Baeuerle PA and Schulze-Osthoff K: Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur J Immunol 25, 159-165 (1995)
33. Miyahara M, Okimasu E, Uchida H, Sato EF, Yamamoto M and Utsumi K: Charge-dependent regulation of NADPH oxidase activities in intact and subcellular systems of polymorphonuclear leukocytes. Biochim Biophys Acta 971, 46-54 (1988)
34. Heyworth PG and Badway JA: Protein phosphorylation associated with the stimulation of neutrophils. Modulation of superoxide production by protein kinase C and calcium. J Bioenerg Biomembr 22, 1-26 (1990)
35. Curnutte JT, Kuver R and Scott PJ: Activation of neutrophil NADPH oxidase in a cell-free system. Partial purification of components and characterization of the activation process. J Biol Chem 262, 5563-5569 (1987)
36. Akimaru K, Utsumi T, Sato EF, Klostergaard J, Inoue M and Utsumi K: Role of tyrosyl phosphorylation in neutrophil priming by tumor necrosis factor-a and granulocyte colony stimulating factor. Arch Biochem Biophys 298, 703-709 (1992)
37. Park JH and Levitt L: Overexpression of mitogen-activated protein kinase (ERK1) enhances T-cell cytokine gene expression: role of API, NF-AT, and NF-κB. Blood 82, 2470-2477 (1993)
38. Gross V, Zhang B, Geng Y, Villiger PM and Lotz M: Regulation of interleukin-6 (IL-6) expression: evidence for a tissue-specific role of protein kinase C. J Clin Immunol 13, 310-320 (1993)
39. Verweij CL, Geerts M and Aarden LA: Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like response element. J Biol Chem 266, 14179-14182 (1991)
40. Zuckerman SH and Evans GF: Endotoxin tolerance: in vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional level. Cell Immunol 140, 513-519 (1992)
41. Pfeuffer I, Klein-Heßling S, Heinfling A, Chuvpilo S, Escher C, Brabletz T, Hentsch B, Schwarzenbach H, Matthias P and Serfling E: Octamer factors exert a dual effect on the IL-2 and IL-4 promoters. J Immunol 153, 5572-5585 (1994)